Use of FoxP3 expression to identify regulatory T cells in healthy dogs and dogs with cancer

Veterinary Immunology and Immunopathology

Volumn 116, Issue 1-2, 2007, Pages 69-78

  Biller, B J ^a   Elmslie, R E ^b   Burnett, R C ^a   Avery, A C ^a   Dow, S W ^a  

^a Department of Environmental and Radiological Health Sciences   (United States)

^b NONE   (United States)

Author keywords

Cytokine; Lymph nodes; Lymphocytes; Melanoma; Osteosarcoma

Indexed keywords

CD4 ANTIGEN; CROSS REACTING ANTIBODY; INTERLEUKIN 10; INTERLEUKIN 2; MESSENGER RNA; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY DETECTION; ANTINEOPLASTIC ACTIVITY; ANTIVIRAL ACTIVITY; ARTICLE; AUTOIMMUNE DISEASE; BLOOD CELL; CANCER; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; DOG; IMMUNE RESPONSE; NONHUMAN; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; TRANSCRIPTION REGULATION;

ANIMALS; DOG DISEASES; DOGS; FLOW CYTOMETRY; FORKHEAD TRANSCRIPTION FACTORS; INTERLEUKIN-10; LYMPH NODES; LYMPHOCYTE ACTIVATION; MELANOMA; OSTEOSARCOMA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STATISTICS, NONPARAMETRIC; T-LYMPHOCYTES, REGULATORY; TRANSFORMING GROWTH FACTOR BETA; TUMOR MARKERS, BIOLOGICAL;

CANIS FAMILIARIS; RODENTIA;

EID: 33847152638     PISSN: 01652427     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetimm.2006.12.002     Document Type: Article

References (41)

1. Allan S.E., Passerini L., Bacchetta R., Crellin N., Dai M., Orban P.C., Ziegler S.F., Roncarolo M.G., and Levings M.K. The role of 2 FOXP3 isoforms in the generation of human CD4+ Tregs. J. Clin. Invest 115 (2005) 3276-3284
2. Almeida A.R., Legrand N., Papiernik M., and Freitas A.A. Homeostasis of peripheral CD4+ T cells: IL-2R alpha and IL-2 shape a population of regulatory cells that controls CD4+ T cell numbers. J. Immunol. 169 (2002) 4850-4860
3. Alvaro T., Lejeune M., Salvado M.T., Bosch R., Garcia J.F., Jaen J., Banham A.H., Roncador G., Montalban C., and Piris M.A. Outcome in Hodgkin's lymphoma can be predicted from the presence of accompanying cytotoxic and regulatory T cells. Clin. Cancer Res. 11 (2005) 1467-1473
4. Antony P.A., and Restifo N.P. CD4 + CD25 + T regulatory cells, immunotherapy of cancer, and interleukin-2. J. Immunother. 28 (2005) 120-128
5. Bacchetta R., Sartirana C., Levings M.K., Bordignon C., Narula S., and Roncarolo M.G. Growth and expansion of human T regulatory type 1 cells are independent from TCR activation but require exogenous cytokines. Eur. J. Immunol. 32 (2002) 2237-2245
6. Baecher-Allan C., and Anderson D.E. Regulatory cells and human cancer. Semin. Cancer Biol. 16 (2006) 98-105
7. Beyer M., and Schultze J.L. Regulatory T cells in cancer. Blood 108 (2006) 804-811
8. Chen W., Jin W., Hardegen N., Lei K.J., Li L., Marinos N., McGrady G., and Wahl S.M. Conversion of peripheral CD4 + CD25- naive T cells to CD4 + CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J. Exp. Med. 198 (2003) 1875-1886
9. Curiel T.J., Coukos G., Zou L., Alvarez X., Cheng P., Mottram P., Evdemon-Hogan M., Conejo-Garcia J.R., Zhang L., Burow M., Zhu Y., Wei S., Kryczek I., Daniel B., Gordon A., Myers L., Lackner A., Disis M.L., Knutson K.L., Chen L., and Zou W. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat. Med. 10 (2004) 942-949
10. Dieckmann D., Plottner H., Berchtold S., Berger T., and Schuler G. Ex vivo isolation and characterization of CD4(+)CD25(+) T cells with regulatory properties from human blood. J. Exp. Med. 193 (2001) 1303-1310
11. Faldyna M., Leva L., Knotigova P., and Toman M. Lymphocyte subsets in peripheral blood of dogs-a flow cytometric study. Vet. Immunol. Immunopathol. 82 (2001) 23-37
12. Fontenot J.D., Gavin M.A., and Rudensky A.Y. Foxp3 programs the development and function of CD4 + CD25+ regulatory T cells. Nat. Immunol. 4 (2003) 330-336
13. Fontenot J.D., and Rudensky A.Y. A well adapted regulatory contrivance: regulatory T cell development and the forkhead family transcription factor Foxp3. Nat. Immunol. 6 (2005) 331-337
14. Fu S., Zhang N., Yopp A.C., Chen D., Mao M., Chen D., Zhang H., Ding Y., and Bromberg J.S. TGF-beta induces Foxp3 + T-regulatory cells from CD4 + CD25-precursors. Am. J. Transplant 4 (2004) 1614-1627
15. Hara M., Kingsley C.I., Niimi M., Read S., Turvey S.E., Bushell A.R., Morris P.J., Powrie F., and Wood K.J. IL-10 is required for regulatory T cells to mediate tolerance to alloantigens in vivo. J. Immunol. 166 (2001) 3789-3796
16. Hori S., Nomura T., and Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 299 (2003) 1057-1061
17. Ichihara F., Kono K., Takahashi A., Kawaida H., Sugai H., and Fujii H. Increased populations of regulatory T cells in peripheral blood and tumor-infiltrating lymphocytes in patients with gastric and esophageal cancers. Clin. Cancer Res. 9 (2003) 4404-4408
18. Itoh M., Takahashi T., Sakaguchi N., Kuniyasu Y., Shimizu J., Otsuka F., and Sakaguchi S. Thymus and autoimmunity: production of CD25 + CD4 + naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance. J. Immunol. 162 (1999) 5317-5326
19. Jonuleit H., Schmitt E., Stassen M., Tuettenberg A., Knop J., and Enk A.H. Identification and functional characterization of human CD4(+)CD25(+) T cells with regulatory properties isolated from peripheral blood. J. Exp. Med. 193 (2001) 1285-1294
20. Khattri R., Cox T., Yasayko S.A., and Ramsdell F. An essential role for Scurfin in CD4 + CD25 + T regulatory cells. Nat. Immunol. 4 (2003) 337-342
21. Levings M.K., Sangregorio R., and Roncarolo M.G. Human cd25(+)cd4(+) t regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function. J. Exp. Med. 193 (2001) 1295-1302
22. Liu W., Putnam A.L., Xu-Yu Z., Szot G.L., Lee M.R., Zhu S., Gottlieb P.A., Kapranov P., Gingeras T.R., de St Groth B.F., Clayberger C., Soper D.M., Ziegler S.F., and Bluestone J.A. CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4 + Treg cells. J. Exp. Med. 203 (2006) 1701-1711
23. Liyanage U.K., Moore T.T., Joo H.G., Tanaka Y., Herrmann V., Doherty G., Drebin J.A., Strasberg S.M., Eberlein T.J., Goedegebuure P.S., and Linehan D.C. Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma. J. Immunol. 169 (2002) 2756-2761
24. Morgan M.E., van Bilsen J.H., Bakker A.M., Heemskerk B., Schilham M.W., Hartgers F.C., Elferink B.G., van der Zanden L., de Vries R.R., Huizinga T.W., Ottenhoff T.H., and Toes R.E. Expression of FOXP3 mRNA is not confined to CD4 + CD25 + T regulatory cells in humans. Hum. Immunol. 66 (2005) 13-20
25. Nakamura K., Kitani A., and Strober W. Cell contact-dependent immunosuppression by CD4(+)CD25(+) regulatory T cells is mediated by cell surface-bound transforming growth factor beta. J. Exp. Med. 194 (2001) 629-644
26. Nuttall T.J., Knight P.A., McAleese S.M., Lamb J.R., and Hill P.B. T-helper 1, T-helper 2 and immunosuppressive cytokines in canine atopic dermatitis. Vet. Immunol. Immunopathol. 87 (2002) 379-384
27. Ormandy L.A., Hillemann T., Wedemeyer H., Manns M.P., Greten T.F., and Korangy F. Increased populations of regulatory T cells in peripheral blood of patients with hepatocellular carcinoma. Cancer Res. 65 (2005) 2457-2464
28. Ramsdell F. Foxp3 and natural regulatory T cells: key to a cell lineage?. Immunity 19 (2003) 165-168
29. Rozen and Skaletsky, 1998; Primer 3. Code available at http://www-genome.wi.mit.edu/genome software/other/primer3.html.
30. Sakaguchi S. Regulatory T cells: key controllers of immunologic self-tolerance. Cell 101 (2000) 455-458
31. Schaefer C., Kim G.G., Albers A., Hoermann K., Myers E.N., and Whiteside T.L. Characteristics of CD4 + CD25 + regulatory T cells in the peripheral circulation of patients with head and neck cancer. Br. J. Cancer 92 (2005) 913-920
32. Shevach E.M. Regulatory T cells in autoimmmunity*. Annu. Rev. Immunol. 18 (2000) 423-449
33. Shevach E.M. CD4 + CD25 + suppressor T cells: more questions than answers. Nat. Rev. Immunol. 2 (2002) 389-400
34. Thornton A.M., and Shevach E.M. CD4 + CD25 + immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J. Exp. Med. 188 (1998) 287-296
35. Vahlenkamp T.W., Tompkins M.B., and Tompkins W.A. Feline immunodeficiency virus infection phenotypically and functionally activates immunosuppressive CD4 + CD25 + T regulatory cells. J. Immunol. 172 (2004) 4752-4761
36. Viguier M., Lemaitre F., Verola O., Cho M.S., Gorochov G., Dubertret L., Bachelez H., Kourilsky P., and Ferradini L. Foxp3 expressing CD4 + CD25(high) regulatory T cells are overrepresented in human metastatic melanoma lymph nodes and inhibit the function of infiltrating T cells. J. Immunol. 173 (2004) 1444-1453
37. Walker M.R., Kasprowicz D.J., Gersuk V.H., Benard A., Van Landeghen M., Buckner J.H., and Ziegler S.F. Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4 + CD25-T cells. J. Clin. Invest. 112 (2003) 1437-1443
38. Walter C.U., Biller B.J., Lana S.E., Bachand A.M., and Dow S.W. Effects of chemotherapy on immune responses in dogs with cancer. J. Vet. Intern. Med. 20 (2006) 342-347
39. Wolf D., Wolf A.M., Rumpold H., Fiegl H., Zeimet A.G., Muller-Holzner E., Deibl M., Gastl G., Gunsilius E., and Marth C. The expression of the regulatory T cell-specific forkhead box transcription factor FoxP3 is associated with poor prognosis in ovarian cancer. Clin. Cancer Res. 11 (2005) 8326-8331
40. Yagi H., Nomura T., Nakamura K., Yamazaki S., Kitawaki T., Hori S., Maeda M., Onodera M., Uchiyama T., Fujii S., and Sakaguchi S. Crucial role of FOXP3 in the development and function of human CD25 + CD4 + regulatory T cells. Int. Immunol. 16 (2004) 1643-1656
41. Ziegler S.F. FOXP3: of mice and men. Annu. Rev. Immunol. 24 (2006) 209-226